Cargando…

Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed countries. The role of complement in the development of AMD is now well-established. While some studies show evidence of complement dysregulation within the eye, others have demonstrated elevated syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warwick, Alasdair, Khandhadia, Samir, Ennis, Sarah, Lotery, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470180/ https://www.ncbi.nlm.nih.gov/pubmed/26237601 http://dx.doi.org/10.3390/jcm3041234

Ejemplares similares

Complement factor I and age-related macular degeneration
por: Alexander, Philip, et al.
Publicado: (2014)

Chlamydia infection status, genotype, and age-related macular degeneration
por: Khandhadia, Sam, et al.
Publicado: (2012)

Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment
por: Khan, Adnan H., et al.
Publicado: (2023)

The complement system in age-related macular degeneration
por: Armento, Angela, et al.
Publicado: (2021)

Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank
por: Tzoumas, Nikolaos, et al.
Publicado: (2022)

Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Complement system and age-related macular degeneration: drugs and challenges
por: Wu, Jiali, et al.
Publicado: (2019)

Complement System and Potential Therapeutics in Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2021)

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
por: Akyol, Engin, et al.
Publicado: (2020)

Epigenetic Age Acceleration Is Not Associated with Age-Related Macular Degeneration
por: Saptarshi, Neil, et al.
Publicado: (2021)

Dysregulated metabolic pathways in age-related macular degeneration
por: Zhang, Meng, et al.
Publicado: (2020)

“Complement-ary” Therapies for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Role of Complement in the Onset of Age-Related Macular Degeneration
por: Piri, Niloofar, et al.
Publicado: (2023)

Epigenetics in age-related macular degeneration: new discoveries and future perspectives
por: Gemenetzi, M., et al.
Publicado: (2020)

Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration
por: Mohan, Rohith R., et al.
Publicado: (2016)

Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration
por: Zysset-Burri, Denise C., et al.
Publicado: (2020)

Macular thickness varies with age-related macular degeneration genetic risk variants in the UK Biobank cohort
por: Kaye, Rebecca A., et al.
Publicado: (2021)

Y chromosome mosaicism is associated with age-related macular degeneration
por: Grassmann, Felix, et al.
Publicado: (2018)

Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian Randomization
por: Jones, Amy V., et al.
Publicado: (2022)

Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration
por: Jensen, Emilie Grarup, et al.
Publicado: (2020)

Socioeconomic risk factors and age-related macular degeneration in the UK Biobank study
por: Yip, Jennifer Lai Yee, et al.
Publicado: (2021)

Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
por: Smailhodzic, Dzenita, et al.
Publicado: (2014)

Genetic variation in complement regulators and susceptibility to age-related macular degeneration
por: Cipriani, Valentina, et al.
Publicado: (2012)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
por: Patel, Prem N., et al.
Publicado: (2022)

Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
por: Keenan, Tiarnan D.L.
Publicado: (2021)

Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration
por: Hallam, Thomas M., et al.
Publicado: (2020)

Structural basis for complement factor H–linked age-related macular degeneration
por: Prosser, Beverly E., et al.
Publicado: (2007)

Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice
por: Landowski, Michael, et al.
Publicado: (2019)

Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model
por: Thomas, Darren S, et al.
Publicado: (2022)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Systematic Review
por: Lin, Jonathan B., et al.
Publicado: (2022)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
por: Lin, Jonathan B., et al.
Publicado: (2022)

Regulation of age-related macular degeneration-like pathology by complement factor H
por: Toomey, Christopher B., et al.
Publicado: (2015)

Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration
por: Wyatt, M. Keith, et al.
Publicado: (2013)

Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
por: Qin, Shuqi, et al.
Publicado: (2021)

Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration
por: Demirs, John T., et al.
Publicado: (2021)

An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
por: Biggs, Robyn M., et al.
Publicado: (2022)

Challenges in studying geographic atrophy (GA) age-related macular degeneration: the potential of a new mouse model with GA-like features
por: Ratnayaka, J. Arjuna, et al.
Publicado: (2019)

Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration
por: Hammadi, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eubisortf814va3ev0jabp8j7g